Leukemia & LymphomaFiegl, M., Mitterbauer, G., Weltermann, A., Pirc-Danoewinata, H., and Jager, U. (1999). Chronic myelogenous leukemia in chronic phase for 16 years: ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy. Leukemia ...
Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase: results from a single-group, phase 2, open-label study. Ann Intern Med. 2018;168:461–70. Article PubMed Google Scholar Nicolini FE, Dulucq S, Boureau L, Cony-Makhoul ...
leukemia reaction. This clinical report presents an observation of a long remission of patient with chronic myeloid leukemia (CML) with mixed hemopoietic chymerism after allo-BMT, persisting during 78 months, which was conirmed by the results of molecular genetic studies by luorescent in situ ...
See what to expect with chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, and learn how it's treated. WebMD takes you through the stages, from diagnosis and tests to relapse and remission.
Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needsIn CML, treatment-free remission (TFR) refers to having a stable deep molecular response without the need for ongoing tyrosine kinase inhibitor treatment. Whilst recommendations exist about the ...
被引量: 10发表: 2010年 A long-term follow-up of observation in treatment-free remission in patients with chronic myeloid leukemia Introduction.The option of observation without therapy with tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) patients is already include... A Petrova...
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs), approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and remain in treatment-free remission (TFR). The ALLG CML8 study enrolled 40 imatinib-treated patients with undetectable BC...
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study. Leukemia. 2017;31:1525-31.Hochhaus A, Masszi T, Giles FJ et al. Treatment-free remission following frontline nilotinib in patients with chronic ...
A 48-year-old man underwent a myeloablative conditioning matched unrelated donor allogeneic hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) with tacrolimus plus methotrexate as graft-vs-host-disease (GVHD) prophylaxis. The donor was a cytomegalovirus seropositive 33-year-...
Lenalidomide (L) induces high response rates with molecular remission in patients (pts) with relapsed (rel) or refractory (ref) chronic lymphocytic leukemia (CLL). 喜欢 0 阅读量: 24 作者: K Miller,MS Czuczman,L Dimiceli,S Padmanabhan,D Lawrence,Z Bernstein,K Takeshita,D Spaner,C Byrne,...